Author:
Krishnan Navasona,Koveal Dorothy,Miller Daniel H,Xue Bin,Akshinthala Sai Dipikaa,Kragelj Jaka,Jensen Malene Ringkjøbing,Gauss Carla-Maria,Page Rebecca,Blackledge Martin,Muthuswamy Senthil K,Peti Wolfgang,Tonks Nicholas K
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology
Reference45 articles.
1. Slamon, D.J. et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707–712 (1989).
2. Tiwari, R.K., Borgen, P.I., Wong, G.Y., Cordon-Cardo, C. & Osborne, M.P. HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis. Anticancer Res. 12, 419–425 (1992).
3. Engelman, J.A. & Settleman, J. Acquired resistance to tyrosine kinase inhibitors during cancer therapy. Curr. Opin. Genet. Dev. 18, 73–79 (2008).
4. Rexer, B.N. & Arteaga, C.L. Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene–amplified breast cancer: mechanisms and clinical implications. Crit. Rev. Oncog. 17, 1–16 (2012).
5. Tonks, N.K. Protein tyrosine phosphatases–from housekeeping enzymes to master regulators of signal transduction. FEBS J. 280, 346–378 (2013).
Cited by
311 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献